New Findings from Mansoura University in the Area of Sodium-Glucose Transporter 2 Inhibitors Described (DPP-4i versus SGLT2i as modulators of PHD3/HIF-2a pathway in the diabetic kidney).

Předmět:	SODIUM-glucose cotransporter 2 inhibitors KIDNEYS TYPE 1 diabetes
Zdroj:	Diabetes Week; 11/6/2023, p218-218, 1p
Abstrakt:	Antihyperglycemics, Drugs and Therapies, Empagliflozin Therapy, Health and Medicine, Kidney, Nephrology, Pharmaceuticals, Sodium-Glucose Transporter 2 Inhibitors, Vildagliptin Therapy Keywords: Antihyperglycemics; Drugs and Therapies; Empagliflozin Therapy; Health and Medicine; Kidney; Nephrology; Pharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Vildagliptin Therapy EN Antihyperglycemics Drugs and Therapies Empagliflozin Therapy Health and Medicine Kidney Nephrology Pharmaceuticals Sodium-Glucose Transporter 2 Inhibitors Vildagliptin Therapy 218 218 1 11/06/23 20231106 NES 231106 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Researchers detail new data in sodium-glucose transporter 2 inhibitors. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu